South & Central America Cerebrospinal Fluid Management Market Forecast to 2030

South & Central America Cerebrospinal Fluid Management Market Forecast to 2030

South & Central America Cerebrospinal Fluid Management Market Forecast to 2030 – Regional Analysis – by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

Send Enquiry
Item ID: TIPRE00027992 Category: Tag:

$2,485 – $3,885

Description

The South & Central America cerebrospinal fluid management market was valued at US$ 92.52 million in 2022 and is expected to reach US$ 123.89 million by 2030; it is estimated to grow at a CAGR of 3.7% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the South & Central America Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson’s Disease (PD), Alzheimer’s Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer’s disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer’s disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

South & Central America Cerebrospinal Fluid Management Market Overview

The cerebrospinal fluid management market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The growth of the market in the region is expected due to several opportunities offered by increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies and growing geriatric population.

South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

South & Central America Cerebrospinal Fluid Management Market Segmentation

The South & Central America cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the South & Central America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the South & Central America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America cerebrospinal fluid management market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the South & Central America cerebrospinal fluid management market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 3.7% CAGR, the South & Central America Cerebrospinal Fluid Management Market is speculated to be worth US$ 123.89 million by 2030, says The Research Team

According to The Research Team’ research, the South & Central America cerebrospinal fluid management market was valued at US$ 92.52 million in 2022 and is expected to reach US$ 123.89 million by 2030, registering a CAGR of 3.7% from 2022 to 2030. Increasing cases of cerebrospinal fluid leak is among the critical factors attributed to the South & Central America cerebrospinal fluid management market expansion.

Shunts for hydrocephalus require an average of 10 revisions during the patient’s lifetime. The risk of diagnosis and treatment failure, limited control options, and complications have offered various opportunities for product developers. Advancements in medical technologies have allowed companies in the cerebrospinal fluid management market to introduce “smart shunts,” offering hi-tech control, diagnosis, and communication-based solutions. Smart shunts can control CSF drainage based on feedback from one or more measurement parameters inbuilt in shunt. Additionally, researchers expect that smart shunts have the potential to offer sophisticated control over mechanical operations by providing data about shunt malfunction. It is further expected to reduce the risk of shunt obstructions, eventually, lowering the chances of failures. Late-stage product development companies operating in the cerebrospinal fluid management market demand experimental results to seek approvals and commercialize smart shunts. The primary focus is on shunts designed to assess cerebrospinal fluid pressure noninvasively in physicians’ offices or at home through an implanted pressure sensor and shunts. Hence, the ongoing technological advancements are leading to significant trends such as smart shunts the South & Central America cerebrospinal fluid management market.

On the contrary, risk of failure and malfunctioning hampers on the growth of South & Central America cerebrospinal fluid management market.

Based on product, the South & Central America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held 82.9% share of South & Central America cerebrospinal fluid management market in 2022, amassing US$ 76.68 million. It is projected to garner US$ 104.53 million by 2030 to expand at 3.9% CAGR during 2022–2030.

Based on end user, the South & Central America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held 49.3% share of South & Central America cerebrospinal fluid management market in 2022, amassing US$ 45.61 million. It is projected to garner US$ 64.15 million by 2030 to expand at 4.4% CAGR during 2022–2030.

Based on country, the South & Central America cerebrospinal fluid management market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 39.1% share of South & Central America cerebrospinal fluid management market in 2022. It was assessed at US$ 36.13 million in 2022 and is likely to hit US$ 51.70 million by 2030, exhibiting a CAGR of 4.6% during 2022–2030.

Key players operating in the South & Central America cerebrospinal fluid management market are B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, and Spiegelberg GmbH & Co KG, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America cerebrospinal fluid management market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Cerebrospinal Fluid Management Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
5. South & Central America Cerebrospinal Fluid Management Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
5.2 Market Restraints
5.2.1 Risk of Failure and Malfunctioning
5.3 Market Opportunities
5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
5.4 Future Trends
5.4.1 Development of Smart Cerebrospinal Fluid Shunts
5.5 Impact Analysis:
6. Cerebrospinal Fluid Management Market – South & Central America Market Analysis
6.1 South & Central America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 South & Central America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
7.3.1 Overview
7.3.2 CSF Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Ventriculoperitoneal Shunts
7.3.3.1 Overview
7.3.3.2 Ventriculoperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Ventriculoatrial Shunts
7.3.4.1 Overview
7.3.4.2 Ventriculoatrial Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Ventriculopleural Shunts
7.3.5.1 Overview
7.3.5.2 Ventriculopleural Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Lumboperitoneal Shunts
7.3.6.1 Overview
7.3.6.2 Lumboperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
7.4.1 Overview
7.4.2 CSF Drainage Systems: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 External Ventricular Drainage (EVD) Systems
7.4.3.1 Overview
7.4.3.2 External Ventricular Drainage (EVD) Systems: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Lumbar Drainage (LD) Systems
7.4.4.1 Overview
7.4.4.2 Lumbar Drainage (LD) Systems: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 South & Central America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Cerebrospinal Fluid Management Market – Country Analysis
9.1 Overview
9.1.1.1 South & Central America Cerebrospinal Fluid Management Market, by Country
9.1.1.2 Brazil
9.1.1.2.1 Overview
9.1.1.2.2 Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.3 Brazil: South & Central America Cerebrospinal Fluid Management Market, by Product
9.1.1.2.3.1 Brazil: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.2.3.2 Brazil: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.2.4 Brazil: South & Central America Cerebrospinal Fluid Management Market, by End User
9.1.1.3 Argentina
9.1.1.3.1 Overview
9.1.1.3.2 Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.3 Argentina: South & Central America Cerebrospinal Fluid Management Market, by Product
9.1.1.3.3.1 Argentina: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.3.3.2 Argentina: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.3.4 Argentina: South & Central America Cerebrospinal Fluid Management Market, by End User
9.1.1.4 Rest of South & Central America
9.1.1.4.1 Overview
9.1.1.4.2 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.4.3 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by Product
9.1.1.4.3.1 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.4.3.2 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.4.4 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market, 2020-2023
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Integra LifeSciences Holdings Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 B. Braun SE
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Spiegelberg GmbH & Co KG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Cerebrospinal Fluid Management Market Segmentation
Table 2. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 3. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 4. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 5. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 6. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 7. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 8. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 9. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 10. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 11. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 12. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 13. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Recent Inorganic Growth Strategies in the South & Central America Cerebrospinal Fluid Management Market
Table 15. Recent Organic Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market
Table 16. Glossary of Terms, South & Central America Cerebrospinal Fluid Management Market

LIST OF FIGURES

Figure 1. South & Central America Cerebrospinal Fluid Management Market Segmentation, By Country
Figure 2. South & Central America – PEST Analysis
Figure 3. South & Central America Cerebrospinal Fluid Management Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. South & Central America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
Figure 6. South & Central America Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 – 2030
Figure 7. South & Central America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. CSF Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Ventriculoperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Ventriculoatrial Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Ventriculopleural Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Lumboperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. CSF Drainage Systems: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. External Ventricular Drainage (EVD) Systems: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lumbar Drainage (LD) Systems: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. South & Central America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
Figure 17. Hospitals: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Clinics: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Ambulatory Surgical Centers: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: South & Central America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. South & Central America Cerebrospinal Fluid Management Market, by Key Country-Revenue (2022) ($Mn)
Figure 22. South & Central America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
Figure 23. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market, 2020-2023

The List of Companies – South and Central America Cerebrospinal Fluid Management Market

o B. Braun SE
o Integra LifeSciences Holdings Corp
o Medtronic Plc
o Spiegelberg GmbH & Co KG

Reviews

There are no reviews yet.

Be the first to review “South & Central America Cerebrospinal Fluid Management Market Forecast to 2030”